Structure via PubChem · Public domain (PubChem)
Chemical data
- Formula
- C20H33N3O3
- Molecular weight
- 363.5 g/mol
- IUPAC name
- 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea
- SMILES
- CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O
- InChIKey
- MXFWWQICDIZSOA-UHFFFAOYSA-N
- XLogP
- 2.6
- Polar surface area
- 82.6 Ų
- H-bond donors
- 4
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- cardiovascular disease, morbid obesity
via ChEMBL · EBI
Research
278 papersvia PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 363.252
- Has use
- medication
Show 6 more facts
- route of administration
- oral administration
- chemical formula
- C₂₀H₃₃N₃O₃
- canonical SMILES
- CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O
- defined daily dose
- 0.1
- subject has role
- beta blocker
- Commons category
- Talinolol
Sources (3)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- Stereochemistry
- References
Talinolol is a beta blocker.
== Stereochemistry == Talinolol contains a stereocenter and consists of two enantiomers. This is a racemate, i.e. a 1: 1 mixture of (R)- and the (S)-forms: {| class="wikitable" style="text-align:center" |- class="hintergrundfarbe6" ! colspan="2"| Enantiomers of talinolol |- | 300 px (R)-talinololCAS number: 71369-60-3 | 300 px (S)-talinololCAS number: 71369-59-0 |}
Excerpted from Wikipedia’s “talinolol” article, available under the CC BY-SA 4.0 licence.